SCHEMBL26857063

SCHEMBL26857063

CN1CCCCC1CNC(=O)c1cc(-c2ccc3nc(N)nn3c2)cs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 1/20 0.43
▸ MAPK8 P45983 1/20 0.42
▸ MAPK10 P53779 1/20 0.42
▸ ADORA2A P29274 3/20 0.41
▸ ADORA1 P30542 3/20 0.41
▸ IKBKB O14920 1/20 0.41
▸ PIK3CG P48736 4/20 0.40
▸ PIK3CA P42336 3/20 0.40
▸ MMP12 P39900 5/20 0.40
▸ PIK3CD O00329 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ TTK P33981 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26856937 0.87 PIK3CG (0.48) ADORA2AADORA1PIK3CGPIK3CAMMP12
SCHEMBL26856930 0.87 PIK3CG (0.47) ADORA2AADORA1PIK3CGPIK3CAMMP12
SCHEMBL26857060 0.86 TTK (0.45) MAPK8MAPK10PIK3CGPIK3CAMMP12
SCHEMBL26856993 0.83 HPGD (0.44) PIK3CGPIK3CAMMP12KDM4EALDH1A1
SCHEMBL26856936 0.82 HPGD (0.47) KDM4EALDH1A1LMNAPOLBMAPT
SCHEMBL26856933 0.81 PIK3CA (0.46) MAPK8MAPK10ADORA2AADORA1PIK3CG
SCHEMBL26857148 0.81 MARK3 (0.46) PIK3CGPIK3CAMMP12PIK3CDTTK
SCHEMBL26856997 0.81 MAPK8 (0.44) MAPK8MAPK10ADORA2AADORA1PIK3CG
SCHEMBL26856887 0.81 PIK3CG (0.41) MAPK8PIK3CGPIK3CAPIK3CDALDH1A1
SCHEMBL26856893 0.80 PIK3CG (0.41) MAPK8PIK3CGPIK3CAMMP12PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF SNCA, PSEN2, PARK7 MALT1 526/4885MAPK8 3191/4885MAPK10 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback